Abiopharma

🔍 Shah Dharmesh (Executive)

Company: HUBSPOT INC (HUBS)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 578 shares of Common Stock at $251.11 per share (Direct)
  Date: 2026-09-01 | Code: F | equity_swap_involved: false | shares_owned_after: 1,293,809.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: See Footnote. | shares_owned_after: 16,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-09-01 | Code: H | nature_of_ownership: See Footnote. | shares_owned_after: 11,000.00 | Footnotes: F3

Footnotes:

• F1: Shares withheld by Issuer to cover taxes associated with settlement of restricted stock units.
• F2: Shares held by the Polaris I Trust, for which Dharmesh Shah serves as trustee. The reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
• F3: Shares held by the Polaris II Trust, for which Dharmesh Shah serves as trustee. The reporting person disclaims beneficial ownership of these securities in excess of his pecuniary interest therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.